Profile picture

Professor Giuseppe Danilo Norata

University of Milan, Milan (Italy)
Membership: ESC Professional Member
Follow
Biography
Giuseppe Danilo Norata, Prof, PhD, is a Professor of Pharmacology at the Department of Pharmacological and Biomolecular Sciences and Coordinator of the Doctorate School of Experimental and Clinical Pharmacological and Biomolecular Sciences at the University of Milan, Italy. His research focuses on vascular and cardiometabolic diseases, with a special interest in immunometabolism. He leads the Laboratory of Pharmacology of CardioImmunoMetabolic Disorders. Professor Norata has held academic positions at Curtin University (Australia), Queen Mary University of London, and the Karolinska Institute (Sweden). He serves as an Editor for Cardiovascular Research and Atherosclerosis and is on the editorial board of Atherosclerosis, Thrombosis, and Vascular Biology (ATVB). He has published over 250 papers on lipid metabolism, atherosclerosis, and immunometabolic diseases and is Chair of the EAS Congress Committee and a member of the AVB Working Group of the European Society of Cardiology.
Logo ESC

Contributor content

Module E: industrial applications - Advanced models of drug testing for cardiac diseases
Session
Module E: industrial applications - Advanced models of drug testing for cardiac diseases
14 June 2026
Atherosclerosis: prevention and new regression
Session
Atherosclerosis: prevention and new regression
1 September 2025
Late-Breaking Basic & Translational Science
Session
Late-Breaking Basic & Translational Science
31 August 2025
Atherosclerosis and thrombosis
Session
Atherosclerosis and thrombosis
4 June 2025
Innovating the clinical management of LDL-c: exploring CETP as therapeutic target
Session
Innovating the clinical management of LDL-c: exploring CETP as therapeutic target
30 August 2024
Antibodies in atherosclerosis
Session
Antibodies in atherosclerosis
12 April 2024
Novel targets for treatment of atherosclerosis
Session
Novel targets for treatment of atherosclerosis
26 August 2023
Targeting lipids and lipid-related pathways in cardiovascular disease
Session
Targeting lipids and lipid-related pathways in cardiovascular disease
28 August 2022
Metabolic interfaces in vascular disease
Session
Metabolic interfaces in vascular disease
3 September 2019

ESC 365 is supported by